Cryotherapy Market Size, Share & Industry Analysis, By Product Type (Cryotherapy Systems and Consumables), By Application (Surgical Applications [Oncology, Dermatology, Cardiology, and Others], Pain Management, and Others), By End User (Hospitals & ASCs, Specialty Clinics, Homecare Settings, and Others), and Regional Forecast, 2026-2034

The global cryotherapy market size was valued at USD 376.8 million in 2025. The market is projected to grow from USD 398.2 million in 2026 to USD 575.8 million by 2034, exhibiting a CAGR of 4.7% during the forecast period.

Cryotherapy is a therapeutic technique that uses extremely low temperatures to destroy abnormal tissue, further reducing pain and inflammation, and promoting healing. The rising prevalence of chronic diseases, growing demand for minimally invasive procedures, and the expansion of wellness and aesthetic applications are resulting in a growing adoption rate of these procedures in the market. The increasing technological advancements in cryotherapy products are further supporting the demand for these procedures among patients in the market.

• For instance, according to the 2025 data published by the National Cancer Institute (NCI), about 2.0 million new cases of cancer were projected to occur in the U.S.

Additionally, the rising integration of technological advancements in these products among the major players, such as Medtronic, Zimmer MedizinSystems, among others, is further contributing to the demand for these products in the market.

Cryotherapy Market Trends

Rising Technological Advancements in Cryotherapy Products to Boost Product Demand

Technological innovation is emerging as a defining trend in the global market, especially in clinical-grade cryosurgical products used in cardiology, oncology, and interventional radiology. The advanced cryotherapy products feature multi-probe capability, real-time temperature monitoring, image-guided navigation including CT, MRI, ultrasound compatibility, and automated freeze–thaw cycle control, enhancing procedural precision and safety outcomes.

Furthermore, the integration of cryotherapy products with hybrid operating rooms and minimally invasive interventional suites is further boosting the investment in healthcare settings, particularly in developed countries. Also, the expansion of portable and handheld dermatology cryotherapy devices to outpatient and office-based settings is likely to boost the adoption rate in the market. 

• In October 2025, IceCure Medical received U.S. Food and Drug Administration (FDA) marketing authorization for ProSense, a minimally invasive cryoablation treatment for patients with early-stage low-risk breast cancer when combined with adjuvant endocrine therapy for women aged 70 and over in the U.S.

Market Dynamics

Market Drivers

Download Free sample to learn more about this report.

Increasing Prevalence of Chronic Disorders to Drive Market Growth

The rising burden of chronic disorders, including cardiovascular disorders, cancer, and others, is resulting in the growing number of cryotherapy procedures among the patient population, further driving the demand for cryotherapy products in the market.

• For instance, according to 2024 statistics published by the Centers for Disease Control & Prevention (CDC), approximately 1 in 20 adults has coronary artery disease in the U.S.

This, coupled with cryoablation procedures, is becoming a well-established treatment option for various types of cancer and atrial fibrillation, further boosting the adoption rate of these products in the market. Therefore, the factors mentioned above, coupled with the growing emphasis of key companies on introducing research and development activities to launch innovative products, are anticipated to fuel the adoption rate of these products, thereby supporting the global cryotherapy market growth.

Other Prominent Drivers

• Growing demand for non-invasive aesthetic and recovery treatments.
• Rising sports medicine adoption among professional and amateur athletes for faster recovery.
• An increasing number of cryotherapy clinics, wellness centres, and aesthetic clinics are offering services.

Market Restraints

High Cost Associated with Cryotherapy Systems to Limit the Market Growth

The increasing upfront capital cost required for advanced cryosurgical products remains a major restraint in the global market, especially in developing and resource-constrained healthcare facilities. Additionally, the additional costs, including maintenance and service contracts, consumables, and others, further add to the financial burden.

Furthermore, these costs make it challenging for small- and mid-sized hospitals, ambulatory surgical centers, and clinics in emerging countries to adopt advanced devices, thereby hampering the penetration and growth of the market.

• For instance, according to the 2026 data published by Necole Bitchie, the price of a cryotherapy machine ranges between USD 30,000 and USD 80,000.

Market Opportunities

Underpenetrated Emerging Markets Present Lucrative Opportunity

The emerging economies across Asia-Pacific, Latin America, the Middle East, and parts of Africa represent a lucrative growth opportunity for the global market. The cryosurgical systems are well established in developed markets; however, penetration remains comparatively low in emerging markets owing to limited healthcare infrastructure, capital constraints, and slower adoption of advanced technology.

However, certain factors, such as the expansion of private hospital networks, growing prevalence rates of chronic conditions, increasing medical tourism in these regions, among others, are resulting in the rapid advancement of the healthcare infrastructure in the market. Therefore, rapid advancement is creating an opportunity for start-ups and the expansion of major companies in these regions.

• According to 2025 data published by Medical Tourism Business, about 3 million foreign patients travel to Thailand each year for medical care.

Market Challenges

Competition from Alternative Energy-based Technologies to Hamper the Market Growth

One of the prominent challenges is growing competition from alternative energy-based ablation technologies, including microwave ablation (MWA), radiofrequency (RF) ablation, laser ablation, and high-intensity focused ultrasound (HIFU). These modalities are increasingly adopted across various applications, such as cardiology, and others, further hampering the penetration rate for cryotherapy procedures in the market.

Furthermore, a limited number of clinical facilities, limited professionals, and an inadequate reimbursement framework, among others, are some of the additional factors, resulting in the limited adoption of procedures among the patient population, particularly in developing nations, such as Mexico, Brazil, among others.

• For instance, according to 2025 data published by Science Direct, over 300,000 catheter ablation procedures with radiofrequency and cryoballoon techniques were registered in Germany.

Other Prominent Challenges

• Regulatory scrutiny and limited standardized clinical evidence for some claimed benefits.
• Safety concerns and contraindications limit adoption in certain patient groups.

SEGMENTATION ANALYSIS

By Product Type

Increasing Prevalence of Chronic Conditions Led to the dominance of the Consumables Segment

Based on the product type, the market is classified into cryotherapy systems and consumables.

To know how our report can help streamline your business, Speak to Analyst

The consumables segment held the largest revenue share in 2025. The growth is primarily due to the rising prevalence of chronic disorders among patients, resulting in an increasing number of cryotherapy procedures and the adoption of consumables such as liquid nitrogen and others in the healthcare settings. This, coupled with the growing focus of key companies on launching consumables, is further expected to contribute to the cryotherapy market share.

• For instance, according to 2024 statistics published by the American Academy of Dermatology Association (AAD), approximately 50 million Americans are suffering from acne in the U.S.

The consumables segment is expected to grow at a CAGR of 4.8% over the forecast period.

By Application

Increasing Prevalence of Chronic Disorders Led to the Dominance of the Surgical Applications Segment

Based on application, the market is segmented into surgical applications, pain management, and others. Surgical applications are further divided into oncology, dermatology, cardiology, and others.

The surgical applications segment dominated the global market in 2025. By application, the surgical applications segment accounted for 62.8% in 2025. The growth is owing to the growing prevalence of chronic conditions, including cancer, cardiovascular conditions, resulting in an increasing demand for cryosurgical procedures, thereby supporting the adoption rate of these products in the market.

• For instance, according to the 2024 statistics published by the Centers for Disease Control and Prevention (CDC), it was reported that about 12.1 million people have atrial fibrillation in the U.S.

The segment of pain management is set to flourish with a growth rate of 4.4% across the forecast period.

By End-user

Growing Number of Hospitals and Cryotherapy Procedures Led to Hospitals & ASCs Segmental Dominance

Based on end user, the market is segmented into hospitals & ASCs, specialty clinics, homecare settings, and others.

The hospitals & ASCs segment dominated the market in 2025. The rising prevalence of chronic diseases, rising number of hospitals, the growing number of cryotherapy procedures in hospitals, among others, are some of the prominent factors contributing to the growth of the segment in the market. Furthermore, the segment is set to hold a 63.7% share in 2026.

• For instance, according to 2021 statistics published by Helgi Library, there are about 901 general hospitals in Italy.

In addition, specialty clinics’ end users are projected to grow at a 4.5% CAGR during the forecast period.

Cryotherapy Market Regional Outlook

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

The North America market held the dominant share in 2024, valued at USD 141.8 million, and also accounted for the leading share in 2025, valued at USD 149.6 million. The rising prevalence of chronic conditions, growing cryotherapy procedures, increasing clinic density, and technological advancements in these products, among others, are some of the crucial factors supporting the growth of the segment in the market.

• For instance, according to statistics published by the Centers for Disease Control & Prevention (CDC), about 218,893 new lung cancers were reported in the U.S. in 2022.

U.S. Cryotherapy Market

Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market is expected to hit USD 138.8 million in 2026, accounting for roughly 34.9% of global sales.

Europe

The European market is projected to grow at a 4.2% CAGR over the coming years, with the second-largest share among regions, and to reach a valuation of USD 111.8 million by 2026. The strong aesthetic market, medical cryotherapy usage, and strong regulatory frameworks are likely to support the market growth.

U.K Cryotherapy Market

The U.K. market in 2026 is estimated at around USD 21.5 million, representing roughly 5.4% of global revenues.

Germany Cryotherapy Market 

Germany’s market is projected to reach approximately USD 25.6 million in 2026, equivalent to around 6.4% of global sales.

Asia Pacific

The Asia Pacific market is estimated to reach USD 95.1 million in 2026 and secure the position of the third-largest region in the market. The growth in cryotherapy procedures, development of healthcare infrastructure, growing adoption in wellness hubs, expanding device sales, and improving healthcare access are anticipated to support the region's growth in the cryotherapy market. In the region, India and China are both estimated to reach USD 12.4 million and USD 24.7 million, respectively, in 2026.

Japan Cryotherapy Market

The Japan market in 2026 is estimated at around USD 26.2 million, accounting for roughly 6.6% of global revenues. Japan has historically reported a relatively increasing prevalence of chronic conditions, with a growing adoption rate of cryotherapy products.

China Cryotherapy Market

China’s market is projected to be one of the largest worldwide, with 2026 revenues estimated at around USD 24.7 million, representing roughly 6.2% of global sales.

India Cryotherapy Market

The India market size in 2026 is estimated at around USD 12.4 million, accounting for roughly 3.1% of global revenues.

Latin America and Middle East & Africa  

The Latin America and Middle East & Africa regions are expected to witness moderate growth in this market space during the forecast period. The Latin America market is set to reach a valuation of USD 18.7 million in 2026.  The growth is due to the growing cryotherapy centers and aesthetic clinics in the region. The Middle East & Africa are also expected to grow due to the rising adoption of wellness and sports facilities. In the Middle East & Africa, the GCC is set to reach a value of USD 7.8 million in 2026.

South Africa Cryotherapy Market

The South Africa market is projected to reach around USD 3.5 million in 2026, representing roughly 0.9% of global revenues.

Competitive Landscape

Key Industry Players

Increasing Number of Product Approvals by Key Companies to Support Their Dominance

A robust and diversified product portfolio, along with a significant focus on strategic initiatives globally, is one of the crucial factors supporting the dominance of these key market companies. Medtronic and Zimmer MedizinSystems are major companies in the market in 2025. Furthermore, the growing emphasis of key companies on receiving product approvals is anticipated to strengthen their presence, further contributing to the global cryotherapy market share.

• For instance, in November 2023, Medtronic received CE approval for the Nitron CryoConsole with an aim to advance the treatment of atrial fibrillation.

Other key players, including Boston Scientific Corporation and others, are also growing in the market, primarily due to their growing emphasis on collaborations among other companies to strengthen their brand presence in the market.

List of Key Cryotherapy Companies Profiled

• Medtronic (U.S.)
• Boston Scientific Corporation (U.S.)
• Zimmer MedizinSystems (Germany)
• IceCure Medical (Israel)
• Articure, Inc. (U.S.)
• CooperSurgical, Inc. (U.S.)
• Erbe Elektromedizin GmbH (Germany)
• CryoPen, Inc. (U.S.)
• Brymill Cryogenic Systems (U.S.)
• Keeler Ltd. (U.K.)

KEY INDUSTRY DEVELOPMENTS

• February 2026: IceCure Medical announced Thomas Hospital of Fairhope purchased and installed the ProSense(R) system in Alabama with an aim to increase its brand presence.
• November 2025: IceCure Medical received approval for the ProSense system and cryoprobes from Swissmedic, the Swiss Agency for Therapeutic Products, with the aim of widening its portfolio.
• July 2025: IceCure Medical, developer of minimally invasive cryoablation technology, participated in the 33rd Annual Meeting of the Japanese Breast Cancer Society's Conference to raise awareness about their product ProSense.
• October 2024: AtriCure, Inc., a company dedicated to developing surgical treatments and therapies, launched the cryoSPHERE MAX cryoablation probe.
• August 2023: Boston Scientific Corporation received U.S. FDA approval for the POLARx Cryoablation System for the treatment of patients with paroxysmal atrial fibrillation (AF).
• August 2023: Boston Scientific Corporation receivedS. FDA approval for its cryoablation portfolio, the VISUAL Ice system. This helped the company in strengthening its presence.
• February 2022: Medtronic, a global player in healthcare technology, announced that the Freezor and Freezor Xtra Cardiac Cryoablation Focal Catheters received approval from the U.S. FDA to treat the pediatric atrioventricular nodal reentrant tachycardia (AVNRT).

REPORT COVERAGE

The report provides a detailed global cryotherapy market analysis and focuses on key aspects such as leading companies and market segmentation, including product type, application, and end user. Besides this, the global report offers insights into the market growth trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth and advancement of the market over recent years.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation